C. Ola Landgren, MD, PhD

Is MRD the same for novel agents as for transplantation?

10/19/2018

Column

Role of MRD as Prognostic Indicator, Clinical Trial Endpoint for Multiple Myeloma

04/16/2019

Journal of Clinical Pathways is pleased to present a new section called “CME Corner,” which will highlight, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers....

...

04/16/2019

Journal of Clinical Pathways

Approaching MRD in Multiple Myeloma

C. Ola Landgren , MD, PhD;

08/29/2020

Debate. Smoldering Myeloma: To Treat or Not to Treat? Yes

C. Ola Landgren , MD, PhD;

08/29/2020

Treatment of smoldering myeloma: the majority of patients should receive therapy

C. Ola Landgren , MD, PhD;

10/24/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

C. Ola Landgren, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products